OI
Oncologic, Inc. / DE
SEC filingOther · Orlando, FL
Amount raised$26.7Msold at filing
Total offering$26.7M
Investors in the raise3count reported to the SEC
FiledAug 5, 2026first sale Jul 20, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Willem BritzExecutive Officer
Sireesha ToletiDirector
Clynt TaylorExecutive Officer
Chakravarthy ToletiExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.